At the news
? NEUTRALIMPACT 3/10 S-3ASR filed May 15, 2026 at 17:02 ET
Insmed filed an automatic shelf registration (S-3ASR) covering an indeterminate amount of common stock and debt securities. The filing provides maximum financial flexibility after reporting strong Q1 2026 results with revenue up 230% YoY and an EPS beat. No specific offering is announced, and the shelf is likely opportunistic rather than a distress-driven capital raise.
- Registers common stock and debt securities in indeterminate amounts for continuous offering under Rule 415
- Insmed qualifies as a well-known seasoned issuer, effective immediately upon filing
- Proceeds to be used for working capital and general corporate purposes
- Follows strong Q1 2026 earnings: revenue $306M (+230% YoY) and EPS beat of -$0.76 vs consensus -$0.90
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access